USA Expands Smallpox Treatment Stockpile

In COVID-19, Latest News by Precision Vaccinations

The U.S. Food and Drug Administration (FDA) announced the Approval of Tembexa (brincidofovir) to treat smallpox.
Tembexa, an oral antiviral, was developed in conjunction with the U.S. Biomedical Advanced Research and Development Authority (BARDA). 
The FDA granted Approval of Tembexa to Chimerix Inc.
Although the World Health Organization declared smallpox eradicated in 1980, there have been longstanding concerns that the virus that causes smallpox, the variola virus, could be used as a bioweapon.

Read More